Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
Trump did, however, reference a potential carve out for oil from Canada, saying that rate would be 10% versus the 25% planned for other goods from the United States' northern neighbor. But he ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Needham analyst Joseph Stringer has maintained their neutral stance on VRTX stock, giving a Hold rating today. Joseph Stringer has given his Hold rating due to a combination of factors surrounding ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...
The first phase of the Champions League is over. Liverpool lost 3-2 away at PSV on Wednesday but remained top of the table after Barcelona could only draw with Atalanta. Arsenal ensured they ...
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
If you're in the market for a new scope, I recommend VX-6HD GEN 2 models over standard VX-6HD models. Hunters shouldn't swap every VX-HD scope they already have on their rifles for a GEN 2 unless ...
New from Leupold, the VX 6-HD Gen. 2 riflescopes takes an existing winning platform and adds to it internal and external upgrades that really make it stand out with hunters looking for the very best.
The new VX-6HD Gen 2 scopes feature all those standard Gold Ring features built around the precision adjustments that have made Mark 5HD Black Ring scopes successful in precision rifle competitions.
The VX One Australian Championship concluded today at the Royal Prince Alfred Yacht Club (RPAYC), and a new Australian Champion was crowned. The Beast AUS352, skippered by Jordan Barney, with siblings ...
Vertex won FDA approval for its newest CF drug, Alyftrek on Dec. 20, 2024. This therapy seems likely to become the new standard of care ... 1/2 study evaluating VX-522, a messenger RNA therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results